Cited 31 times in
Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김종찬 | - |
dc.contributor.author | 나군호 | - |
dc.contributor.author | 박지수 | - |
dc.contributor.author | 장원식 | - |
dc.contributor.author | 최영득 | - |
dc.contributor.author | 함원식 | - |
dc.contributor.author | 허지은 | - |
dc.date.accessioned | 2019-07-11T03:06:50Z | - |
dc.date.available | 2019-07-11T03:06:50Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0171-5216 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/169845 | - |
dc.description.abstract | PURPOSE: This study aimed at investigating the prognostic value of Preoperative controlling nutritional status (CONUT) score in non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. METHODS: We retrospectively included 1046 among 1637 patients who underwent radical or partial nephrectomy for solid renal masses ≤ 7 cm (2005-2014) after excluding other pathology, conditions affecting CONUT score components, metastasis, regional lymphadenopathy, positive margin, and follow-up < 12 months. We defined high and low CONUT according to cut-off of (2). Multivariate Cox-regression analysis was used to predict factors affecting recurrence and survival. Kaplan-Meier curve was used for survival analysis. RESULTS: The median age and follow-up were 56 years and 63 months, respectively. 41 patients had recurrence (3.9%). CONUT was a predictor for recurrence-free, cancer-specific, and overall survival (HR 3.09, P = 0.003 and HR 4.66, P = 0.004 and HR 2.81, P = 0.003, respectively). A higher CONUT was significantly associated with worse 5 years recurrence-free (88.2% vs. 97.1%), cancer-specific (96.2% vs. 98.8%) and overall (90.9% vs. 96.5%) survival (log-rank, P = < 0.001, P = 0.006 and P = < 0.001, respectively). CONCLUSIONS: The preoperative CONUT is an independent prognostic marker for survival after curative surgery for non-metastatic clear-cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English, German | - |
dc.publisher | Springer-Verlag | - |
dc.relation.isPartOf | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Carcinoma, Renal Cell/blood | - |
dc.subject.MESH | Carcinoma, Renal Cell/immunology | - |
dc.subject.MESH | Carcinoma, Renal Cell/mortality | - |
dc.subject.MESH | Carcinoma, Renal Cell/surgery* | - |
dc.subject.MESH | Cholesterol/blood | - |
dc.subject.MESH | Disease-Free Survival | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kaplan-Meier Estimate | - |
dc.subject.MESH | Kidney Neoplasms/blood | - |
dc.subject.MESH | Kidney Neoplasms/immunology | - |
dc.subject.MESH | Kidney Neoplasms/mortality | - |
dc.subject.MESH | Kidney Neoplasms/surgery* | - |
dc.subject.MESH | Lymphocyte Count | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Nephrectomy | - |
dc.subject.MESH | Nutritional Status* | - |
dc.subject.MESH | Predictive Value of Tests | - |
dc.subject.MESH | Preoperative Period | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Serum Albumin/metabolism | - |
dc.title | Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Urology (비뇨의학교실) | - |
dc.contributor.googleauthor | Ahmed Elghiaty | - |
dc.contributor.googleauthor | Jongchan Kim | - |
dc.contributor.googleauthor | Won Sik Jang | - |
dc.contributor.googleauthor | Jee Soo Park | - |
dc.contributor.googleauthor | Ji Eun Heo | - |
dc.contributor.googleauthor | Koon Ho Rha | - |
dc.contributor.googleauthor | Young Deuk Choi | - |
dc.contributor.googleauthor | Won Sik Ham | - |
dc.identifier.doi | 10.1007/s00432-019-02846-x | - |
dc.contributor.localId | A04541 | - |
dc.contributor.localId | A01227 | - |
dc.contributor.localId | A05336 | - |
dc.contributor.localId | A05268 | - |
dc.contributor.localId | A04111 | - |
dc.contributor.localId | A04337 | - |
dc.contributor.localId | A05531 | - |
dc.relation.journalcode | J01283 | - |
dc.identifier.eissn | 1432-1335 | - |
dc.identifier.pmid | 30758671 | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs00432-019-02846-x | - |
dc.subject.keyword | Immunity | - |
dc.subject.keyword | Nephrectomy | - |
dc.subject.keyword | Non-metastatic clear cell renal cell carcinoma | - |
dc.subject.keyword | Nutrition | - |
dc.contributor.alternativeName | Kim, Jong Chan | - |
dc.contributor.affiliatedAuthor | 김종찬 | - |
dc.contributor.affiliatedAuthor | 나군호 | - |
dc.contributor.affiliatedAuthor | 박지수 | - |
dc.contributor.affiliatedAuthor | 장원식 | - |
dc.contributor.affiliatedAuthor | 최영득 | - |
dc.contributor.affiliatedAuthor | 함원식 | - |
dc.contributor.affiliatedAuthor | 허지은 | - |
dc.citation.volume | 145 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 957 | - |
dc.citation.endPage | 965 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Vol.145(4) : 957-965, 2019 | - |
dc.identifier.rimsid | 62379 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.